SARS-CoV-2 M <sup>pro</sup> inhibitors: identification of anti-SARS-CoV-2 M <sup>pro</sup> compounds from FDA approved drugs
Shiv Bharadwaj, Esam I. Azhar, Mohammad Amjad Kamal, Leena H. Bajrai, Amit Dubey, Kanupriya Jha, Umesh Yadava, Sang Gu Kang, Vivek Dhar Dwivedi
Abstract
studies against SARS-CoV-2 infection.Communicated by Ramaswamy H. Sarma.
Topics & Concepts
Docking (animal)ChemistryCoronavirusIn vivoStereochemistrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DarunavirPharmacologyVirologyCoronavirus disease 2019 (COVID-19)MedicineVirusBiologyViral loadPathologyDiseaseBiotechnologyInfectious disease (medical specialty)NursingAntiretroviral therapyComputational Drug Discovery MethodsSARS-CoV-2 and COVID-19 Researchthermodynamics and calorimetric analyses